Skip to main content
Decorative image of the AMR Learning Lounge

Sepsis and Antimicrobial Resistance: A Deadly Intersection

PUBLICATION DATE: September 03, 2025 LAST EDIT: September 04, 2025

SUMMARY

Learning Lounge Viewpoints Series | July 2025

When antimicrobial resistance (AMR) and sepsis collide, the stakes for patient survival become even more critical. The rapid progression of sepsis is made increasingly dangerous by rising resistance, demanding smarter, more comprehensive clinical diagnostics and antimicrobial stewardship (AMS) practices. In this exclusive Viewpoints Series interview, Cecilia Carvalhaes, MD, PhD, shares practical strategies to integrate fast diagnostics, multidisciplinary teamwork, and innovative therapies to improve patient outcomes — even in challenging healthcare settings.

FEATURED EXPERT

Cecilia Carvalhaes, MD, PhD, Global Medical Affairs Advisor, bioMérieux


GET STARTED

Discover actionable insights and practical strategies to help your team break the deadly cycle of sepsis and AMR.

Read Now

Filename
LL-Viewpoints-Series_Sepsis-and-AMR_Deadly-Intersection---Cecilia-Carvalhaes_July.pdf
Size
525 KB
Format
application/pdf

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


GLOBAL STEWARDSHIP SOLUTIONS

Learn how VITEK® REVEAL™ can help identify resistant organisms earlier, supporting timely AMR interventions in critical cases like sepsis.

YOU MAY ALSO LIKE

Sébastien Spinali, MD, explains the urgent need for innovative diagnostic tools and refined treatment protocols to balance timely sepsis intervention with AMS practices.


SHARE THIS ARTICLE: